Answers are grounded in this paper and cite their sources.
Preliminary findings show Majoon Ushba alleviates inflammation in psoriasis, highlighting potential therapy benefits.
In conclusion, our preliminary findings reveal a plausible mechanistic basis for the anti-psoriatic efficacy of Majoon Ushba, warranting larger clinical trials in psoriasis patient cohorts.
No takes yet. Share an insight, caveat, or question.
Rithvik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: